Boc-L-Nle-OH*DCHA

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25628

CAS No:21947-32-0

Synonyms/Alias:Boc-Nle-OHDCHA;21947-32-0;N-((tert-bUtoxy)carbonyl)-L-norleucine,compoundwithdicyclohexylamine(1:1);boc-nle-oh.dcha;Boc-Nle-OHCHA;Boc-Nle-OH?DCHA;CTK1A6914;MolPort-016-580-270;C23H44N2O4;EINECS244-673-0;1108AB;AKOS015903280;CB-1692;RTR-010289;AK-81138;Boc-L-Nle-OH(dicyclohexylammonium)salt;KB-300022;TR-010289;ST24046235;K-6223;I14-18575;N-(tert-Butoxycarbonyl)-L-norleucine-N-cyclohexylcyclohexanamine(1:1);L-Norleucine,N-[(1,1-dimethylethoxy)carbonyl]-,compd.withN-cyclohexylcyclohexanamine(1:1)

Chemical Name:N-alpha-t-Butyloxycarbonyl-L-norleucine dicyclohexylamine, (S)-N-alpha-Boc-2-aminohexanoic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C23H44N2O4
M.W/Mr.
231,29*181,32 g/mole

Boc-L-Nle-OH*DCHA is a Boc-protected L-norleucine amino acid supplied as a dicyclohexylamine (DCHA) salt, combining a protected amine for controlled peptide coupling with a side chain well-suited to hydrophobic residue placement in synthetic sequences. The Boc group enables standard protected-amino-acid workflows, while the DCHA salt form supports handling and consistent reactivity for peptide assembly and intermediate preparation in peptide chemistry laboratories.

1. Solid-Phase Peptide Synthesis

Boc-L-Nle-OH*DCHA is used as a protected norleucine building block for constructing hydrophobic peptide segments where a methylene-extended leucine-like side chain is desired. Peptide synthesis groups commonly select this Boc-protected, salt-form amino acid to streamline coupling steps in automated or semi-automated workflows, enabling reliable incorporation of an unbranched aliphatic residue into peptide libraries and sequence-specific constructs. The Boc protection pattern supports iterative assembly strategies that rely on orthogonal control of the amino functionality during chain elongation.

2. Peptide Library And SAR Building

Boc-L-Nle-OH*DCHA supports medicinal chemistry and chemical biology programs that generate peptide panels for structure-activity relationship (SAR) studies, where systematic variation of hydrophobic residue content is used to tune peptide conformation and interaction profiles. Research groups preparing analog series often value norleucine for replacing or complementing branched hydrophobic amino acids to probe how side-chain topology influences downstream behavior. As a protected amino acid salt, it is convenient for routine procurement and consistent performance across parallel synthesis campaigns, including custom peptide manufacturing and in-house peptide library production.

3. Pharmaceutical Intermediate Development

Boc-L-Nle-OH*DCHA is also used in the development and scale-up of protected amino acid intermediates that feed into downstream peptide or peptidomimetic synthesis. Process and development chemists incorporate this Boc-protected norleucine derivative as a controlled, isolable precursor when building larger coupling-ready fragments for specialty chemical manufacturing. The presence of the Boc-protected amine and the DCHA counterion form supports practical handling in intermediate workflows, helping maintain reproducible reactivity when preparing multiple batches for project timelines.

4. Hydrophobic Residue Substitution Studies

Boc-L-Nle-OH*DCHA is frequently employed in peptide and peptidomimetic design studies that require substitution of hydrophobic residues to evaluate sequence-dependent properties. Chemical biology teams use norleucine-containing analogs to modulate side-chain length and branching relative to common proteinogenic residues, supporting experimental mapping of how local hydrophobic character contributes to folding propensity, stability trends, and interaction patterns within peptide systems. The Boc-protected form supports controlled assembly of these analogs using established protected-amino-acid coupling workflows rather than requiring additional side-chain or amino-function protection steps.

Size
5 g;25 g;
InChI
1S/C12H23N.C11H21NO4/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12;1-5-6-7-8(9(13)14)12-10(15)16-11(2,3)4/h11-13H,1-10H2;8H,5-7H2,1-4H3,(H,12,15)(H,13,14)/t;8-/m.0/s1
InChI Key
BFEVJIUEBDZIJQ-WDBKTSHHSA-N
Canonical SMILES
CCCCC(C(=O)O)NC(=O)OC(C)(C)C.C1CCC(CC1)NC2CCCCC2

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesPeptide Analysis ServicesCustom Conjugation ServicePeptide CDMOPeptide Modification ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesiscGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers